Cost effectiveness of quadrivalent influenza vaccines in the elderly population of Malaysia

Author:

Aljunid Syed Mohamed,Mad Tahir Nur Syazana,Ismail Aniza,Abdul Aziz Aznida Firzah,Azzeri Amirah,Zafirah S. A.,Aizuddin Azimatun Noor

Abstract

AbstractThe economic burden of influenza is a significant issue within healthcare system, related to higher medical costs particularly among the elderly. Yet, influenza vaccination rates in the elderly in Malaysia were considerably low as it is not part of Malaysia’s national immunization program, with substantial mortality and morbidity consequences. Therefore, we conducted a cost-effectiveness analysis of quadrivalent influenza vaccine (QIV) for the elderly in Malaysia compared with the current no-vaccination policy. A static cost-utility model, with a lifetime horizon based on age, was used for the analysis to assess the cost-effectiveness and health outcomes associated with QIV. Univariate and probabilistic sensitivity analyses were performed to test the effects of variations in the parameters. The use of QIV in Malaysia’s elderly population would prevent 66,326 potential influenza cases and 888 potential deaths among the elderly, leading to 10,048 potential quality-adjusted life years (QALYs) gained. The QIV would also save over USD 4.4 million currently spent on influenza-related hospitalizations and reduce productivity losses by approximately USD 21.6 million. The ICER per QALY gained from a third-party payer’s perspective would be USD 2216, which is lower than the country’s gross domestic product per capita. A QIV-based vaccination program in the elderly was found to be highly cost-effective, therefore would reduce the financial burden of managing influenza and reduce pre-mature death related to this disease.

Funder

Sanofi Aventis

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference49 articles.

1. Thompson, M. G. et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine 36, 5916–5925 (2018).

2. Mad Tahir, N. S. et al. Clinical pathway for influenza in the elderly: A comprehensive management protocol of Malaysia. Asia Pac. J. Heal. Manag. 17, 1–14 (2022).

3. World Health Organization. Influenza (seasonal). Fact sheet. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal) (2018).

4. Sam, J. I. C. C. The burden of human influenza in Malaysia. Med. J. Malays. 70, 127–130 (2015).

5. Saat, Z. et al. Seasonal influenza virus strains circulating in Malaysia from 2005 to 2009. Southeast Asian J. Trop. Med. Public Health 41, 1368–1373 (2010).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3